JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 35
Type: Contributed
Date/Time: Sunday, July 29, 2012 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #303949
Title: A Phase II Design for Combination Codevelopment Based on the Probability of Correct Selection
Author(s): Xinyu Tang*+ and Xinyu Tang
Companies: University of Arkansas for Medical Sciences and University of Arkansas for Medical Sciences
Address: 1 Children's Way, Little Rock, AR, 72202, United States
Keywords: Phase II design ; Investigational drugs ; Factorial design ; Time-to-event endpoint

The United States Food and Drug Administration (FDA) (2010) has recently issued a draft guidance entitled "Guidance for industry - codevelopment of two or more unmarketed investigational drugs for use in combination." In the case where each of the two investigational drugs has some activity and both can be given individually, the guidance recommends that a four-arm Phase II factorial design should be used to compare the combination of two investigational drugs to each drug alone and to placebo or standard of care. The aim of the design is to establish contribution of each component in Phase II without exposing a large number of patients to relatively ineffective treatments, enabling a simple two-arm randomized Phase III trial to be conducted. We used Green's criteria (Green 2006) for selecting the best treatment in a factorial design using a time-to-event endpoint as the basis of a Phase II strategy relying on the probability of correct selection concept applied to a progression-free survival endpoint. We claim that selection of the combination as the best agent using Green's criteria may provide evidence of component contribution in Phase II trials.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.